SCHEMBL3907712

SCHEMBL3907712

CCOC(=O)COc1c(C(=O)OC)sc(-c2cccc(OCc3cccc(OC(F)(F)F)c3)c2)c1Br

nearest known ligand 0.54

Predicted protein targets (top 12)

geneUniProtsupporting neighboursconfidence
PTPN1 P18031 10/20 0.54
MRGPRX4 Q96LA9 2/20 0.43
PPARD Q03181 2/20 0.41
MMP2 P08253 1/20 0.39
MMP9 P14780 1/20 0.39
MMP14 P50281 1/20 0.39
ADAM17 P78536 1/20 0.39
MAOB P27338 1/20 0.39
PPARG P37231 1/20 0.39
PPARA Q07869 1/20 0.39
F9 P00740 1/20 0.39
F10 P00742 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3909104 0.90 PTPN1 (0.66) PTPN1PPARGPPARAF9F10
SCHEMBL3905901 0.89 PTPN1 (0.56) PTPN1MRGPRX4F9F10
SCHEMBL3911789 0.89 PTPN1 (0.53) PTPN1
SCHEMBL3909166 0.89 PTPN1 (0.51) PTPN1F9F10
SCHEMBL3910009 0.87 PTPN1 (0.55) PTPN1ADAM17F9F10
SCHEMBL3907399 0.85 PTPN1 (0.64) PTPN1F9F10
SCHEMBL6268163 0.84 PTPN1 (0.55) PTPN1PPARGPPARAF9F10
SCHEMBL3909316 0.82 PTPN1 (0.79) PTPN1
SCHEMBL6278145 0.82 PTPN1 (0.79) PTPN1
SCHEMBL3917412 0.82 PTPN1 (0.61) PTPN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7521473-B2 Inhibitors of protein tyrosine phosphatase 1B WYETH (US) 2009-04-21 US disclosed
US-20050203087-A1 Inhibitors of protein tyrosine phosphatase 1B WYETH 2005-09-15 US disclosed
WO-2005081954-A2 INHIBITORS OF PROTEIN TYROSINE PHOSPHATASE 1B WYETH (US) 2005-09-09 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050203087-A1 Inhibitors of protein tyrosine phosphatase 1B PTPRO, PTPRS, PTPRM PTPN1 11/4885MRGPRX4 3999/4885PPARD 1414/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.